Home > Insider Trading > Filing (0000899243-22-039166)

Filing Details

Accession Number:: 0000899243-22-039166
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-21 16:05:22
Reporting Period:: 2022-12-20

Accepted Time:: 2022-12-21 16:05:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
31791	Perkinelmer Inc	PKI	Laboratory Analytical Instruments (3826)	042052042

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1440132	S Joel Goldberg	940 Winter Street Waltham MA 02451	Please See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-20	35,907	$41.80	56,757	No	4	M	Direct
Common Stock	Disposition	2022-12-20	1,800	$137.05	54,957	No	4	S	Direct
Common Stock	Disposition	2022-12-20	10,439	$138.36	44,518	No	4	S	Direct
Common Stock	Disposition	2022-12-20	23,668	$139.21	20,850	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	NQ Stock Option (right to buy)	Disposition	2022-12-20	35,907	$0.00	35,907	$41.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-02-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	63,709	Indirect	By Goldberg Irrevocable 2021 Trust

Footnotes

The Exercise Price included on the Form 4 filed on February 10, 2016 for the Reporting Person was incorrectly reported due to administrative error.
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Goldberg on May 26, 2022.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $136.64 to $137.46. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $137.74 to $138.73. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $138.74 to $139.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Securities held in an irrevocable trust for the sole benefit of the reporting person's children. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
This option became exercisable in three equal annual installments beginning on February 9, 2017, which was the first anniversary of the date on which the option was granted.